(NASDAQ: IART) Integra Lifesciences Holdings's forecast annual revenue growth rate of 5.97% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.29%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.08%.
Integra Lifesciences Holdings's revenue in 2024 is $1,541,573,000.On average, 8 Wall Street analysts forecast IART's revenue for 2024 to be $126,222,711,448, with the lowest IART revenue forecast at $125,394,129,318, and the highest IART revenue forecast at $130,354,827,766. On average, 8 Wall Street analysts forecast IART's revenue for 2025 to be $133,836,781,272, with the lowest IART revenue forecast at $131,171,129,390, and the highest IART revenue forecast at $143,648,279,377.
In 2026, IART is forecast to generate $144,307,672,122 in revenue, with the lowest revenue forecast at $139,794,390,816 and the highest revenue forecast at $149,995,032,326.